Genomic Health, Inc. revised earnings guidance for the full year of 2019. For the year, the company now expects to report revenues in the range of $448 million to $452 million, net income in the range of $56 million to $60 million and diluted earnings per share in the range of $1.44 to $1.54 against previous guidance of revenues in the range of $436 million to $448 million, net income in the range of $48 million to $54 million and diluted earnings per share in the range of $1.23 to $1.38 for the same period.